Stocks · News reference
Kyntra Bio (NASDAQ:KYNB) reported quarterly losses of $(4.68) per share which missed the analyst consensus estimate of $(3.18) by 47.17 percent. This is a 148.94 percent decrease over losses of $(1.88) per share from
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
On Thursday, Kyntra Bio (NASDAQ:KYNB) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts and
Read original at benzingaWall Street analysts changed outlook on top names. See analyst rating changes on top stocks. PFGC, SPCX, KC, WELL, KYNB have coverage initiated.
Read original at benzinga